Molecular identification of two types of interleukin-1 receptors in the murine pituitary gland.

The present study was carried out to characterize interleukin-1 (IL-1) receptors on murine pituitary cells. Receptor autoradiography confirmed the existence of binding sites for IL-1 alpha in the murine adenohypophysis, but not in the neural or intermediate lobes. Specific binding of IL-1 to isolated pituitary membranes revealed a Kd of 0.9 nM with a Bmax of 37 fmol/mg protein. To examine the possibility that the adenohypophysis synthesizes a receptor for IL-1, immunocytochemistry experiments with a specific monoclonal antibody against the type I receptor revealed the existence of this protein in only the adenohypophysis. Identity of the type I IL-1 receptor was similar to that found on T cells as determined by: 1) amplification of the predicted 619 bp fragment spanning the cytoplasmic, transmembrane and extracellular domains from RNA of pituitary and T cell origin, as well as clonal AtT-20 pituitary cells, and 2) restriction fragment analysis and sequencing of the amplified cDNAs. The pituitary gland and AtT-20 cells also expressed transcripts for the newly identified type II receptor for IL-1 as assessed by amplification of a specific 325 bp fragment, restriction fragment analysis and nucleotide sequencing, and these transcripts were similar to those found on B lymphocytes. These data identify two different forms of the IL-1 receptor in both normal and transformed pituitary cells and establish that these receptors are similar at the molecular level to those first identified on T and B lymphocytes.

Pituitary epithelial cell implants reverse the accumulation of CD4-CD8- lymphocytes in thymus glands of aged rats.

Although implantation of GH3 pituitary epithelial cells has been shown to reverse thymic aging in rats, the differentiation pattern of T-lymphocytes within the reconstituted thymus glands has not been investigated. Syngeneic GH3 cells were implanted into 22-month-old female (old) Wistar-Furth rats. Eight weeks later, thymus glands and thymocyte subpopulations were compared to those in aged (24-month-old) and young (3-month-old) female Wistar Furth rats. We confirmed that implantation of GH3 cells increased (P less than 0.05) not only thymus size but also the number of thymocytes isolated from aged rats. Flow cytometric analysis using dual color direct immunofluorescence with fluorescein isothiocyanate-labeled anti-CD4 (W3/25) and phycoerythrin-labeled anti-CD8 (OX 8) monoclonal antibodies revealed that thymus glands from young rats had approximately 20% CD4-CD8- and 30% CD4+CD8+ cells. Thymus glands from old rats contained greater than 50% more CD4-CD8- cells and a reduced percentage of CD4+CD8+ lymphocytes compared to those of young rats (P less than 0.05). Moreover, both of these age-associated changes were reversed (P less than 0.05) by implanting GH3 cells. GH3-treated aged rats also had a significantly (P less than 0.05) greater proportion of CD4+CD8- thymocytes compared to aged control rats. There were no differences among the three groups of rats in the percentage of CD4-CD8+ thymocytes or in the percentage or intensity of cells expressing the T-cell markers CD3, T-cell receptor, or OX19. These results show that in aged rats, intrathymic maturation is inhibited at the key transitional stage where double negative cells differentiate into double positive cells, which may limit the diversity of the T-cell repertoire. The data also extend earlier results by demonstrating that GH3 epithelial cells promote not only growth, but also the differentiation of T-lymphocytes in the aging rat thymus.